Gsa Capital Partners LLP Emergent Bio Solutions Inc. Transaction History
Gsa Capital Partners LLP
- $1.35 Billion
- Q4 2024
A detailed history of Gsa Capital Partners LLP transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 51,270 shares of EBS stock, worth $512,700. This represents 0.04% of its overall portfolio holdings.
Number of Shares
51,270Holding current value
$512,700% of portfolio
0.04%Shares
12 transactions
Others Institutions Holding EBS
# of Institutions
162Shares Held
33.2MCall Options Held
453KPut Options Held
931K-
Black Rock Inc. New York, NY3.84MShares$38.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$34 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.49MShares$24.9 Million0.03% of portfolio
-
State Street Corp Boston, MA1.91MShares$19.1 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.73MShares$17.3 Million0.01% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $499M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...